Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 218.86 M221.54 M228.44 M235.77 M247.35 M 933.1 M Research & development 109.12 M108.15 M114.39 M120.26 M112.49 M 455.3 M Operating income -9.44 M-8.24 M611 K-16.41 M-23.57 M -47.61 M Non-Operating Income, Total 17.54 M16.77 M11.31 M13.33 M12.44 M 53.85 M Interest expense, net of interest capitalized 6.35 M6.29 M6.25 M6.25 M6.28 M 25.07 M Non-Operating Income, excl. Interest Expenses -4.59 M-5.36 M-6.75 M-5.8 M-6.44 M -24.35 M Unusual income/expense 15.78 M15.84 M11.81 M12.89 M12.6 M 53.13 M Pretax income -9 0001.31 M6.17 M-9.77 M-17.26 M -19.55 M Equity in earnings ————— — Taxes 24.59 M52.59 M-1.59 M-445.67 M-529 K -395.19 M Non-controlling/minority interest ————— — After tax other income/expense —-33 K0-38 K-6 000 -77 K Net income before discontinued operations -24.6 M-51.28 M7.75 M435.9 M-16.73 M 375.64 M Discontinued operations ————— — Net income -24.6 M-51.28 M7.75 M435.9 M-16.73 M 375.64 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -24.6 M-51.28 M7.75 M435.9 M-16.73 M 375.64 M Basic earnings per share (Basic EPS) -0.23-0.480.074.13-0.16 3.56 Diluted earnings per share (Diluted EPS) -0.23-0.480.074.07-0.16 3.5 Average basic shares outstanding 105.96 M106.59 M104.5 M105.34 M104.64 M — Diluted shares outstanding 105.96 M106.59 M106.2 M107.22 M104.64 M — EBITDA -4.56 M-2.19 M7.71 M-3.3 M-16.6 M -14.39 M EBIT -9.44 M-8.24 M611 K-16.41 M-23.57 M -47.61 M Cost of revenue 96.75 M102.03 M106.44 M111.06 M121.92 M 441.45 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 4.88 M6.04 M7.1 M13.11 M6.97 M 33.22 M